KPRX

Kiora Pharmaceuticals, Inc. - Common Stock (KPRX)

About Kiora Pharmaceuticals, Inc. - Common Stock (KPRX)

Kiora Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.

Details

Daily high

$1.74

Daily low

$1.64

Price at open

$1.71

52 Week High

$2.91

52 Week Low

$1.55

Market cap

7.7M

Dividend yield

Volume

11,208

Avg. volume

58,895

P/E ratio

-.65

Kiora Pharmaceuticals, Inc. - Common Stock News